决明提取物(Senna Extract) - 在研适应症：便秘_专利_临床

概要

基本信息

药物类型

中药

别名

YODEL-S、ヨーデルS

靶点-

作用方式-

作用机制-

治疗领域

其他疾病

在研适应症

便秘

非在研适应症-

原研机构

Fujimoto Pharmaceutical Corp.

在研机构

Fujimoto Pharmaceutical Corp.

非在研机构-

权益机构-

最高研发阶段批准上市

首次获批日期

日本 (1970-03-31),

便秘

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

7

项与决明提取物相关的临床试验

NCT04930237

/ WithdrawnN/AIIT

RELISTOR's Effects on Opioid-Induced Constipation in Postoperative 1-2 Level Anterior Lumbar Interbody Fusion Patients: A Case-Control Study

This will be a prospective case-control study of 40 patients undergoing 1-2 level ALIF procedures at Methodist Dallas Medical Center (MDMC). Patient records will be reviewed to identify details including demographics, comorbidities, procedure details, and the primary and secondary outcome metrics.

开始日期2021-07-01

申办/合作机构

Methodist Health System, Inc.

NCT02977286

/ Terminated临床4期IIT

Impact of Naloxegol on Prevention of Lower GI Tract Paralysis in Critically Ill Adults Initiated on Scheduled Intravenous Opioid Therapy: A Randomized, Double-Blind, Placebo-Controlled, Phase II, Single-Center, Proof of Concept Study

This study evaluates the addition of naloxegol (Movantik) to a laxative protocol in critically ill adults requiring scheduled opioid (e.g. fentanyl) therapy. Half of the participants will receive naloxegol and a laxative protocol and half the participants will receive a placebo and a laxative protocol.

开始日期2017-01-01

申办/合作机构

Tufts Medical Center, Inc.

NCT02383758

/ CompletedN/AIIT

An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders

The purpose of this study is to try to treat bowel movement (BM) accidents differently with children with autism spectrum disorder (ASD). The study will use over-the-counter (OTC) medications to evoke predictable bowel movements. This will make it possible for investigators to use certain strategies to reward BMs in the toilet. Independence will be increased by fading out the use of medications. The investigators will also train caregivers to implement the procedures.

开始日期2015-02-01

申办/合作机构

Emory University

[+1]

100 项与决明提取物相关的临床结果

登录后查看更多信息

100 项与决明提取物相关的转化医学

登录后查看更多信息

100 项与决明提取物相关的专利（医药）

登录后查看更多信息

100 项与决明提取物相关的药物交易

登录后查看更多信息

研发状态

10 条最早获批的记录,

登录

后查看更多信息

适应症	国家/地区	公司	日期
便秘	日本	Fujimoto Pharmaceutical Corp.	1970-03-31

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT02977286 (CTgov)	临床4期	便秘	12	Polyethylene Glycols+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Senna 217 Mg Oral Tablet+Naloxegol Oral Tablet+Methylnaltrexone (Naloxegol Oral Tablet)	淵積窪製鏇廠糧網顧鏇(顧襯窪簾壓窪構願繭鏇) = 繭築壓齋選鹽範齋繭衊鏇衊醖鏇網鏇艱壓膚壓 (顧艱鬱製衊廠壓積蓋鏇, 壓壓壓築衊範選襯選齋 ~ 壓繭願餘齋夢選簾鬱餘) 更多	-	2023-02-16
				Placebo Oral Tablet+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Senna 217 Mg Oral Tablet+Methylnaltrexone (Placebo Oral Tablet)	淵積窪製鏇廠糧網顧鏇(顧襯窪簾壓窪構願繭鏇) = 鹹廠膚繭廠鹽遞積窪淵鏇衊醖鏇網鏇艱壓膚壓 (顧艱鬱製衊廠壓積蓋鏇, 獵壓範齋觸願鑰鹹鑰鏇 ~ 簾餘膚膚糧製鬱襯廠壓) 更多
NCT02383758 (CTgov)	N/A	自闭症谱系障碍 \| 自闭症 \| 大便弄脏	22	Glycerin Suppository+Bisacodyl suppository+Senna (Treatment Program)	膚窪鏇構簾壓鏇膚膚醖(範窪積齋觸遞壓構廠鹹) = 鬱顧鹽製鏇鏇膚窪築顧顧膚憲構遞繭製鑰憲憲 (獵遞願鬱餘窪積廠鹹蓋, 鏇築願憲選蓋膚壓簾鏇 ~ 範積醖蓋壓獵蓋蓋顧獵) 更多	-	2018-01-11
				Glycerin Suppository+Bisacodyl suppository+Senna (Waitlist Control)	膚窪鏇構簾壓鏇膚膚醖(範窪積齋觸遞壓構廠鹹) = 鹹憲願遞鹽遞壓齋構壓顧膚憲構遞繭製鑰憲憲 (獵遞願鬱餘窪積廠鹹蓋, 淵壓顧積獵衊獵觸簾鏇 ~ 簾獵鹹餘鹹鏇蓋願遞衊) 更多